Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CDNA · against 454 other Healthcare companies listed in US-listed
Ranked #116 of 455 · scores higher than 73% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including CDNA · Click a bar to see the companies
Mainly thanks to its revenue growth, earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | CDNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 34.4% | 11.0% | 77% | 33% | |
| Earnings per share growthHigher is better · 171 reported | 96.5% | 21.2% | 81% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 14.0% | 11.0% | 56% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 110 | 1.9B USD | 85 | 47 | |
| 116 | 3.9B USD | 84 | 47 | |
| 116 | 222M USD | 84 | 31 | |
| 116 | 1.1B USD | 84 | 50 | |
| 116 | 4.6B USD | 84 | 65 | |
| 116 | 399M USD | 84 | 32 | |
| 116 | 126M USD | 84 | 32 | |
| 116 | 1.2B USD | 84 | 75 | |
| 116 | 10.7B USD | 84 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score